Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Total article views   HTML views PDF downloads Totals
9,511 Dovepress* 8,664+ 1,275 9,939
PubMed Central* 847 264 1,111
Totals 9,511 1,539 11,050
*Since 5 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar